Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
20.77
+0.53 (2.62%)
At close: Jan 22, 2026, 4:00 PM EST
20.77
0.00 (0.00%)
After-hours: Jan 22, 2026, 4:50 PM EST
Pacira BioSciences Employees
As of December 31, 2024, Pacira BioSciences had 790 total employees, including 788 full-time and 2 part-time employees. The number of employees increased by 78 or 10.96% compared to the previous year.
Employees
790
Change (1Y)
78
Growth (1Y)
10.96%
Revenue / Employee
$907,330
Profits / Employee
$27,137
Market Cap
893.55M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 790 | 78 | 10.96% | 788 | 2 |
| Dec 31, 2023 | 712 | -3 | -0.42% | 711 | 1 |
| Dec 31, 2022 | 715 | 18 | 2.58% | 715 | 0 |
| Dec 31, 2021 | 697 | 73 | 11.70% | 697 | 0 |
| Dec 31, 2020 | 624 | 18 | 2.97% | 624 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,740 |
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 2,028 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 869 |
| BioCryst Pharmaceuticals | 580 |
| Cronos Group | 459 |
| Esperion Therapeutics | 304 |
PCRX News
- 8 days ago - Pacira BioSciences, Inc. (PCRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 9 days ago - Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets - GlobeNewsWire
- 14 days ago - Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues - GlobeNewsWire
- 15 days ago - Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences - GlobeNewsWire
- 23 days ago - DOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc. - PRNewsWire
- 7 weeks ago - Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical - GlobeNewsWire
- 2 months ago - Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences - GlobeNewsWire